List of Contents

In Vitro Diagnostics Market Size, Share, and Trends 2024 to 2034

The global in vitro diagnostics (IVD) market size is calculated at USD 102.05 billion in 2024, grew to USD 104.01 billion in 2025 and is predicted to surpass around USD 132.18 billion by 2034, expanding at a CAGR of 2.62% between 2024 and 2034.

  • Last Updated : December 2024
  • Report Code : 1130
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on In Vitro Diagnostics Market 

5.1. COVID-19 Landscape: In Vitro Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global In Vitro Diagnostics Market, By Product

8.1. In Vitro Diagnostics Market, by Product, 2024-2034

8.1.1. Reagents

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Instruments

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Services

8.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global In Vitro Diagnostics Market, By Test Location

9.1. In Vitro Diagnostics Market, by Test Location, 2024-2034

9.1.1. Point of Care

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Home Care

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Others

9.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global In Vitro Diagnostics Market, By Technology 

10.1. In Vitro Diagnostics Market, by Technology, 2024-2034

10.1.1. Immunoassay

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Hematology

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Clinical Chemistry

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Molecular Diagnostics

10.1.4.1. Market Revenue and Forecast (2021-2034)

10.1.5. Coagulation

10.1.5.1. Market Revenue and Forecast (2021-2034)

10.1.6. Microbiology

10.1.6.1. Market Revenue and Forecast (2021-2034)

10.1.7. Others

10.1.7.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global In Vitro Diagnostics Market, By Application

11.1. In Vitro Diagnostics Market, by Application, 2024-2034

11.1.1. Diabetes

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Cardiology

11.1.2.1. Market Revenue and Forecast (2021-2034)

11.1.3. Nephrology

11.1.3.1. Market Revenue and Forecast (2021-2034)

11.1.4. Infectious Disease

11.1.4.1. Market Revenue and Forecast (2021-2034)

11.1.5. Oncology

11.1.5.1. Market Revenue and Forecast (2021-2034)

11.1.6. Drug Testing

11.1.6.1. Market Revenue and Forecast (2021-2034)

11.1.7. Autoimmune Diseases

11.1.7.1. Market Revenue and Forecast (2021-2034)

11.1.8. Others

11.1.8.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global In Vitro Diagnostics Market, By Others

12.1. In Vitro Diagnostics Market, by Others, 2024-2034

12.1.1. Standalone Laboratories

12.1.1.1. Market Revenue and Forecast (2021-2034)

12.1.2. Hospitals

12.1.2.1. Market Revenue and Forecast (2021-2034)

12.1.3. Academic & Medical Schools

12.1.3.1. Market Revenue and Forecast (2021-2034)

12.1.4. Point-of-Care

12.1.4.1. Market Revenue and Forecast (2021-2034)

12.1.5. Others

12.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 13. Global In Vitro Diagnostics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2021-2034)

13.1.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.1.3. Market Revenue and Forecast, by Technology (2021-2034)

13.1.4. Market Revenue and Forecast, by Application (2021-2034)

13.1.5. Market Revenue and Forecast, by Others (2021-2034)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2021-2034)

13.1.6.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.1.6.3. Market Revenue and Forecast, by Technology (2021-2034)

13.1.6.4. Market Revenue and Forecast, by Application (2021-2034)

13.1.6.5. Market Revenue and Forecast, by Others (2021-2034) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product (2021-2034)

13.1.7.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.1.7.3. Market Revenue and Forecast, by Technology (2021-2034)

13.1.7.4. Market Revenue and Forecast, by Application (2021-2034)

13.1.7.5. Market Revenue and Forecast, by Others (2021-2034)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2021-2034)

13.2.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.2.3. Market Revenue and Forecast, by Technology (2021-2034)

13.2.4. Market Revenue and Forecast, by Application (2021-2034) 

13.2.5. Market Revenue and Forecast, by Others (2021-2034) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2021-2034)

13.2.6.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.2.6.3. Market Revenue and Forecast, by Technology (2021-2034)

13.2.7. Market Revenue and Forecast, by Application (2021-2034) 

13.2.8. Market Revenue and Forecast, by Others (2021-2034) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2021-2034)

13.2.9.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.2.9.3. Market Revenue and Forecast, by Technology (2021-2034)

13.2.10. Market Revenue and Forecast, by Application (2021-2034)

13.2.11. Market Revenue and Forecast, by Others (2021-2034)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2021-2034)

13.2.12.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.2.12.3. Market Revenue and Forecast, by Technology (2021-2034)

13.2.12.4. Market Revenue and Forecast, by Application (2021-2034)

13.2.13. Market Revenue and Forecast, by Others (2021-2034)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2021-2034)

13.2.14.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.2.14.3. Market Revenue and Forecast, by Technology (2021-2034)

13.2.14.4. Market Revenue and Forecast, by Application (2021-2034)

13.2.15. Market Revenue and Forecast, by Others (2021-2034)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2021-2034)

13.3.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.3.3. Market Revenue and Forecast, by Technology (2021-2034)

13.3.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.5. Market Revenue and Forecast, by Others (2021-2034)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2021-2034)

13.3.6.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.3.6.3. Market Revenue and Forecast, by Technology (2021-2034)

13.3.6.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.7. Market Revenue and Forecast, by Others (2021-2034)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2021-2034)

13.3.8.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.3.8.3. Market Revenue and Forecast, by Technology (2021-2034)

13.3.8.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.9. Market Revenue and Forecast, by Others (2021-2034)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2021-2034)

13.3.10.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.3.10.3. Market Revenue and Forecast, by Technology (2021-2034)

13.3.10.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.10.5. Market Revenue and Forecast, by Others (2021-2034)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2021-2034)

13.3.11.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.3.11.3. Market Revenue and Forecast, by Technology (2021-2034)

13.3.11.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.11.5. Market Revenue and Forecast, by Others (2021-2034)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2021-2034)

13.4.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.4.3. Market Revenue and Forecast, by Technology (2021-2034)

13.4.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.5. Market Revenue and Forecast, by Others (2021-2034)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2021-2034)

13.4.6.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.4.6.3. Market Revenue and Forecast, by Technology (2021-2034)

13.4.6.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.7. Market Revenue and Forecast, by Others (2021-2034)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2021-2034)

13.4.8.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.4.8.3. Market Revenue and Forecast, by Technology (2021-2034)

13.4.8.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.9. Market Revenue and Forecast, by Others (2021-2034)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2021-2034)

13.4.10.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.4.10.3. Market Revenue and Forecast, by Technology (2021-2034)

13.4.10.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.10.5. Market Revenue and Forecast, by Others (2021-2034)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2021-2034)

13.4.11.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.4.11.3. Market Revenue and Forecast, by Technology (2021-2034)

13.4.11.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.11.5. Market Revenue and Forecast, by Others (2021-2034)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2021-2034)

13.5.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.5.3. Market Revenue and Forecast, by Technology (2021-2034)

13.5.4. Market Revenue and Forecast, by Application (2021-2034)

13.5.5. Market Revenue and Forecast, by Others (2021-2034)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2021-2034)

13.5.6.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.5.6.3. Market Revenue and Forecast, by Technology (2021-2034)

13.5.6.4. Market Revenue and Forecast, by Application (2021-2034)

13.5.7. Market Revenue and Forecast, by Others (2021-2034)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2021-2034)

13.5.8.2. Market Revenue and Forecast, by Test Location (2021-2034)

13.5.8.3. Market Revenue and Forecast, by Technology (2021-2034)

13.5.8.4. Market Revenue and Forecast, by Application (2021-2034)

13.5.8.5. Market Revenue and Forecast, by Others (2021-2034)

Chapter 14. Company Profiles

14.1. Alere, Inc.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Hoffmann-La Roche Ltd.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Arkray

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Arkray

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Becton Disckinson

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Bio-Rad laboratories

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Danaher

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Sysmex Corporation

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Abbott Laboratories

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global in vitro diagnostics (IVD) market size accounted for USD 102.05 billion in 2024 and is expected to reach USD 132.18 billion by 2034.

The global in vitro diagnostics (IVD) market is exhibiting a compound annual growth rate (CAGR) of around 2.62% from 2024 to 2034.

In recent years, in vitro diagnostics industry has recognized significant developments. Rising geriatric population, prevalence of infectious as well as chronic diseases and existence of automated in vitro diagnosis systems for hospitals to offer precise diagnosis are some of the factors are expected to propel the growth of the market. Thus, growing elderly population and subsequent demand for immunoassay-based tests flourishes the market growth. Additionally, increased government funding and other healthcare organizations investment into in vitro diagnostics market is the key drivers to boost market growth over the forecast period. Growing consciousness on personalized medicines and increasing acceptance of point-of-care testing are also high impact rendering market drivers.

The reagent segment dominated the market in 2023 as reagents are indispensible part of every in vitro diagnostics test. Rising demand for point-of-care tests and self tests and increasing various R&D initiatives are projected to accelerate the growth of this segment.

North America is estimated to top the global market throughout the estimated time period due to high-rise in healthcare awareness among population and its well penetrated healthcare system.

Asia Pacific is projected to witness fastest CAGR in the in vitro diagnostics market over the forecast period. The growth in Asia Pacific has been attributed to the increasing healthcare spending and growing prevalence of diabetes in the region.

The immunoassay dominated the global in vitro diagnostics market in 2023 owing to growing adoption of immunoassay based rapid testing and POC testing.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Plan your call and get expert insights!

Schedule a Meeting Schedule a Meeting

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us